Amyloid Precursor Protein and Alzheimer's Disease

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Alzheimer's disease (AD) is a prevalent neurodegenerative disorder linked to aging and genetic factors.
• AD manifests as severe dementia, impacting memory, cognition, and daily functioning.
• Key pathological hallmarks include amyloid beta (Aβ) and hyperphosphorylated tau accumulation.

Purpose of the Study:

• To explore the role of amyloid precursor protein (APP) in Alzheimer's disease pathology.
• To elucidate the transition from the non-amyloidogenic to the amyloidogenic pathway of APP processing.
• To identify critical gaps in understanding APP biogenesis for future research.

Main Methods:

• Review of existing literature on Alzheimer's disease pathogenesis.
• Analysis of the biochemical pathways involved in amyloid precursor protein (APP) processing.
• Identification of pathological features associated with AD progression.

Main Results:

• Alzheimer's disease (AD) is characterized by the accumulation of cytotoxic amyloid beta (Aβ) and hyperphosphorylated tau.
• Amyloid precursor protein (APP) can follow an amyloidogenic pathway, generating harmful Aβ plaques.
• Synaptic loss, impaired energy metabolism, and homeostasis imbalances contribute to AD progression.

Conclusions:

• The amyloid precursor protein (APP) plays a central role in Alzheimer's disease (AD) pathogenesis.
• Further research is needed to clarify the complete biogenesis pathway of APP.
• AD is a complex multifactorial disease requiring comprehensive therapeutic strategies.